In an adequately powered, randomized controlled trial conducted over 2 years, the desired clinical outcome (i.e. prevention of a serious cardiovascular event) with a new drug is achieved in 25% of the study sample. In the patients who receive a placebo, only 15% obtain the same clinical benefit. The relative risk reduction achieved with the new drug over the study period is:
Lauran
7 months agoPearly
8 months agoMargret
8 months agoKenneth
8 months agoBernardine
8 months agoFrederica
9 months agoGail
9 months agoTamra
9 months agoCary
9 months agoGerardo
9 months agoNatalie
9 months agoDevorah
9 months agoDorathy
9 months agoPhyliss
9 months agoTambra
1 year agoSamuel
1 year agoAudry
1 year agoOzell
1 year agoMarg
1 year agoAltha
1 year agoJamal
1 year agoPamella
1 year agoXenia
1 year agoSkye
1 year agoDeonna
1 year agoElvis
1 year agoDenise
1 year agoJaclyn
1 year agoTimothy
1 year agoYuonne
1 year agoMalcolm
1 year agoKizzy
1 year agoAndrew
1 year agoOmega
1 year agoThea
1 year agoMelynda
1 year agoEllen
1 year agoDaren
1 year agoRuth
1 year ago